Astera Labs, Inc. Common Stock logo ALAB - Astera Labs, Inc. Common Stock

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $372.27 DETAILS
HIGH: $500.00
LOW: $153.00
MEDIAN: $425.00
CONSENSUS: $372.27
UPSIDE: 18.31%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

High-Growth Software 80% confidence

Primary model: Revenue × Terminal Margin DCF

Valuation Signal Overvalued Strong
Trading 380.8% above fair value
Current Price $314.66
Bear Case $32.29 89.7% downside ($32.29 - $314.66) / $314.66 = -89.7% 18% rev growth, 21% terminal margin
Fair Value $65.45 79.2% downside ($65.45 - $314.66) / $314.66 = -79.2% 30% rev growth, 28% terminal margin
Bull Case $91.22 71.0% downside ($91.22 - $314.66) / $314.66 = -71.0% 35% rev growth, 32% terminal margin

Adjust Assumptions

30.0%
28.0%
12.0%

Key Value Driver

Revenue growth (30%) × margin expansion to 28%

Terminal Value % of EV 56%
Implied Market Multiple 61.9x

Plain-Language Summary

Projecting 30% revenue growth with FCF margins expanding from 33% to 28% over 10 years, discounted at 12%, the base-case value is $65.45 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (18 analysts) $372.27
Analyst Range $153.00 – $500.00
Divergence from AlphaVal 82%

Warnings

Gross margin of 76% means each dollar of revenue is highly profitable. As the company grows, overhead costs should shrink as a share of revenue, boosting overall profits.
Wall Street's average price target is $372.27 (from 18 analysts). Our estimate is 82% below the consensus -- consider that gap carefully.

Key Risks

  • Current FCF misleads — the model values future margins, not today's cash
  • SBC dilution is the hidden tax: 2-4% annual share growth compounds fast
  • Revenue deceleration is inevitable — the question is when and how steep